A study conducted by researchers at the University of Pennsylvania School of Medicine indicates that women using weight loss medications similar to Ozempic may have a 30% lower likelihood of developing breast cancer. The findings contribute to the ongoing research into the potential cancer prevention benefits of these drugs.
✓ AI-Debiased Article
15
Public broadcaster
provisional
Study suggests weight loss drugs may reduce breast cancer risk
Researchers at the University of Pennsylvania School of Medicine have found that women taking weight loss medications like Ozempic may be 30% less likely to develop breast cancer. This study adds to the evidence suggesting these drugs could have cancer prevention properties.
Annotating as
No note attached
on this article.
Original vs. Neutral
Original Headline
Women on Ozempic-like drugs are 30% less likely to develop breast cancer: study
Neutral Headline
Study suggests weight loss drugs may reduce breast cancer risk